Carregant...
Review of Venetoclax in CLL, AML and Multiple Myeloma
Venetoclax is a highly selective and effective B-cell lymphoma-2 (BCL-2) inhibitor, which is able to reinstate the apoptotic potential of cancer cells. With its full repertoire yet to be explored, it has changed the therapeutic landscape in haematological malignancies, and most particularly chronic...
Guardat en:
| Publicat a: | J Pers Med |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8225137/ https://ncbi.nlm.nih.gov/pubmed/34073976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11060463 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|